retatrutide glp-1 gip glucagon agonist The TRIUMPH-1 Phase 3 results just dropped on retatrutide. Here is what the numbers actually say. is a triple agonist. It targets GLP-1, GIP, and receptors. Ozempic targets one. Mounjaro Retatrutide Obesity Triple Agonist Targeting

Moreover, the GLP-1R knockout mice self-administered more nicotine than their wildtype counterparts (Tuesta et al., 2012)

FRIDAY, May 23, 2025 (HealthDay News) A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on

P., Lee, J

A few developments had occurred in the software & AI space that I had not anticipated, and rather than continue to take such a granular view into what I expected would be continued market strength, it seemed prudent to have our net exposure higher and not take more risk than necessary on long/short AI until the trend had played out further